Tekla World Healthcare Fund (the “Fund”) announced the terms of its non-transferable rights offering (the “Offer”). The Offer entitles shareholders of record on March 8, 2021 to subscribe for additional common shares of beneficial interest (“Shares”) of the Fund through the exercise of non-transferable rights (“Rights”). The proceeds from the
To strengthen behavioral health services in Solano County, Adventist Health Vallejo, which has served as the county’s behavioral treatment center of choice for nearly 25 years, announced today it has signed a definitive agreement to sell the hospital and its behavioral health services to Acadia Healthcare (NASDAQ: ACHC), a leading
Zhou Jun, Party secretary of NetEase, an internet giant based in Hangzhou, was interviewed ahead of the fifth session of the 13th Zhejiang Provincial People’s Congress on Jan 28. Zhou said he hoped that the digital economy could benefit the public, replacing confusing numbers with considerate services in Hangzhou. In
Many people in our society are underweight and in order to look attractive, they want to gain more body weight. One of the common most desire of such people is “how to gain weight in a week” (https://www.astocare.com/doctors/chandigarh/dietitian). By following certain tips regularly and making minor adjustments in their lifestyle,
Members to Gain Critically Needed Cost Savings and Efficiencies CME Corp., the largest equipment-only distributor of healthcare products in the United States, has been added as a provider by MAGNET GROUP, a cooperative buying group with 9,000 members in 20 states plus the District of Columbia. The three-year contract will
OLYMPIA – The Washington State Department of Health (DOH) has stepped in to provide interim Local Health Officer (LHO) functions to the Island County Health Department effective Jan. 6, 2021. Scott Lindquist, MD, MPH, State Epidemiologist and Acting State Health Officer, initially began serving as the LHO on Dec. 31, 2020
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be
